DGAP-News: Rentschler Biopharma and XL-protein: Efficient production of a hyperactive PASylated DNase I with extended half-life
Rentschler Biopharma and XL-protein demonstrate efficient production of a hyperactive PASylated DNase I with extended half-life. Hyperactive DNase I modified with X